Frailty tests to assess surgical risk in gynecologic cancers
Part of Cancer clinical trials.
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 55 or older when you register
- You have a gynecologic cancer situation that involves planned or ongoing laparotomy (an open abdominal surgery), such as ovarian or endometrial cancer surgery, certain cancer planned for open surgery, a suspicious pelvic mass, or cancer recurrence surgery
- You can provide informed consent and understand study instructions
- You do not need surgery within 24 hours of your first consultation
- You are not currently receiving neoadjuvant radiation therapy (radiation before surgery)
- You do not have a known history of dementia, and you do not have significant hearing, vision, language, or thinking problems that would prevent completing the study questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help gynecologic cancer patients who are frail improve their physical function and quality of life during treatment. It aims to see if extra support can help you stay stronger and recover better.
This study looks at older adults with newly diagnosed epithelial ovarian cancer and checks health factors that can affect treatment, like day-to-day function and support needs. It may help doctors choose better care plans for older patients by understanding risks and needs early.
This study looks at how frailty (weakness and tiredness) affects the daily life and well-being of women 60 or older who have just been diagnosed with a common type of breast cancer. The goal is to understand their needs better so doctors can provide more supportive care.
This study looks at “frailty,” or how well the body may handle stress, around the time of surgery in people age 65 and older. It may help doctors better understand who is at higher risk and how to plan care around surgery.
This trial looks at whether “frailty” (how weak or vulnerable someone is) changes short- and long-term outcomes after surgery. It may help doctors better predict who could benefit from extra support before and after surgery.
This study looks at how certain blood markers (albumin/creatine ratio, vitamin B12, and folate) relate to frailty in older adults having surgery for stomach or intestinal cancer. The goal is to understand if these markers can help predict which patients may be more frail.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.